Characterizing Burnout in Health Professionals: Insights from the BEATS Study in Portugal

By João L. Carapinha

January 27, 2026

Burnout Health Professionals: Join the BEATS Study Call

Burnout health professionals in Portugal are invited to participate in the BEATS study, an initiative by the Portuguese Laboratory for Healthy Work Environments. Titled “BEATS – Burnout, Expectativas e Ambientes de Aprendizagem e Trabalhos Saudáveis” (Burnout, Expectations, and Healthy Learning and Work Environments), it characterizes burnout health professionals and examines workplace ecosystems as protective or risk factors. Collaboration with the Ordem dos Farmacêuticos urges pharmacists’ involvement for representativeness, using an anonymous 15-minute questionnaire for academic purposes.

Workplace ecosystems profoundly influence burnout health professionals experience, acting as safeguards or amplifiers. The BEATS study explores these dynamics in Portuguese health settings, analyzing environmental factors. It targets active practitioners, spotlighting pharmacists to capture profession-specific trends. This ecosystem lens promotes tailored interventions, blending organizational and worker contexts beyond individual evaluations.

The BEATS study’s questionnaire can be completed in 15 minutes by health professionals in Portugal. It stresses sincere responses with no right or wrong answers, upholding anonymity and confidentiality for research only. Participants can opt in or out freely. Led by Prof.ª Doutora Tânia Gaspar from SPIC/Universidade Lusófona, it meets ethical norms, offers clarification contacts, and falls under National Data Protection Authority oversight—ensuring robust burnout data without privacy risks.

BEATS will likely lead to occupational health costs in Portugal. By pinpointing modifiable ecosystems, it guides retention-boosting interventions, curbing absenteeism and turnover in roles like pharmacy. Results could back modeling of policy interventions towards healthy environments, offsetting healthcare spends and aligning with preventive trends for sustainable healthcare delivery.

Reference url

Recent Posts

Rapid Genetic Testing Mitigates Gentamicin-Induced Hearing Loss in Neonates

By João L. Carapinha

March 9, 2026

Rapid genetic testing is dramatically improving neonatal care by detecting the m.1555A>G mitochondrial variant in newborns at risk of profound hearing loss from gentamicin, allowing swift switches to alternative antibiotics without delaying treatment. Developed through the
EMA’s Clinical Trials Guidance for Enhancing Flexibility During Public Health Emergencies
The European Medicines Agency (EMA) has released draft clinical trials guidance for public consultation from 4 March to 30 April 2026. This guidance outlines regulatory flexibi...
Portugal Clinical Trials Regulation: A Comprehensive Framework for EU Compliance and Participant ...
Portugal Aligns with EU Standards Portugal clinical trials regulation is now firmly established through Lei n.º 9/2026, published on March 6, 2026, which implements the European Parliament and Council